News
1h
Zacks Investment Research on MSNCRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?CRISPR Therapeutics AG CRSP shares rallied 9.6% in the last trading session to close at $60.08. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.
Paul Scofield, a project adviser and senior curator of natural history at the Canterbury Museum in Christchurch, New Zealand, ...
Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
18h
AZoLifeSciences on MSNNew Software Boosts Genome Editing Accuracy for Genetic TherapiesThis innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...
Picture juicy red tomatoes on the vine. What do you see? Some tomato varieties have straight vines. Others are branched. The ...
The field of biotechnology has made significant strides in enhancing agricultural productivity by developing crops that can ...
The organizations launched the center with a $20 million CZI grant to build on the success of the first personalized CRISPR base-editing therapy.
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...
KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...
Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results